🔥Telegram İfşa

"Teplizumab's great, but I don't think we'll be using it forever." - John Wentworth of Australasian T1D Immunotherapy Collaborative at #23ADC Teplizumab preventing #T1D is a promising treatment but John's confident that more effective (and more easily given) agents are coming.

Excellent presentation by Dr Rahul D Barmanray at #23ADC describing over 10% of inpatients who had glucose testing (~60% with preexisting diabetes) developed hospital-acquired infections. Work from The Royal Melbourne Hospital

John Wentworth presenting on behalf of Tessa Glyn at #23ADC, findings from a nationwide survey on exercise in #T1D. Appears that people with #T1D prefer sessional education and don't highly rate advice from clinicians, but clinicians feel they're well equipped to advise.

Wah Cheung of Westmead Hospital demonstrating their diabetes dashboard for inpatient #diabetes care at #23ADC. It's all about real-time data linkage for optimising inpatient diabetes care these days.

Who else but Dr Merv K of The Royal Melbourne Hospital to chair an inpatient #diabetes session at #23ADC. His first Australian model of care study to reduce glucose and infection (RAPIDS) is definitely the inspiration and impetus for most (?all) the inpatient diabetes work being done now.

"Virtual care is great but I do want us to still see the patient." -Wah Cheung at #23ADC Important to remember virtual inpatient care tools, certainly in #diabetes, are adjuncts to the clinician's role and do not (?can never) supplant it.

Lois Rowan, diabetes nurse practitioner at The Royal Melbourne Hospital, describing her journey to working in inpatient diabetes at #23ADC. A long journey but one the entire inpatient diabetes team is very glad she took!

Two coinciding studies have identified – and are trying to improve – the increased risk of patients with diabetes contracting infections and suffering acute kidney injury and stroke when in hospital. Full story 👇 thermh.org.au/news/trial-hel…